These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5984051)

  • 1. [The use of cetamiphen in patients with coronary arteriosclerosis].
    Savenkov PM
    Sov Med; 1966 Apr; 29(4):98-100. PubMed ID: 5984051
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cetamiphen on coagulative properties of blood in patients with coronary arteriosclerosis].
    Zelenskaia LM
    Vrach Delo; 1975 Jul; (7):68-70. PubMed ID: 1220236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of cetamiphen and nicotinic acid in the treatment of patients with coronary atherosclerosis].
    Savenkov PM
    Kardiologiia; 1967 Apr; 7(4):50-3. PubMed ID: 5598475
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of cetamiphen on blood sugar level].
    Kozlovskaia OI
    Vrach Delo; 1972 Jul; 7():27-9. PubMed ID: 5083751
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of unithiol, its combination with polyvitamin preparations and cetamiphen in the treatment of patients with cerebral atherosclerosis].
    Kurliandchikov VN
    Vrach Delo; 1972 Sep; 9():24-8. PubMed ID: 4658109
    [No Abstract]   [Full Text] [Related]  

  • 6. [Abnormal lipid metabolism and coronary insufficiency].
    Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
    Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative assessment of the efficacity of certain antilipemic agents in patients with diabetes mellitus].
    Lesnichiĭ AV
    Ter Arkh; 1969 Jul; 41(7):61-4. PubMed ID: 5374413
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
    Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
    Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of various preparations on hyperuricemia in coronary arteriosclerosis].
    Anisimov VE; Goliakov VN; Semavin IE
    Ter Arkh; 1977; 49(9):134-6. PubMed ID: 73228
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative evaluation of treatment of patients with coronary atherosclerosis with nicatol and nicotinic acid].
    Ivanchenko FT
    Vrach Delo; 1967 Jan; 1():76-80. PubMed ID: 4895148
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of coronary atherosclerosis.
    Gould L
    Mod Treat; 1966 May; 3(3):565-78. PubMed ID: 5326566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative evaluation of the hypolipidemic effect of cetamiphen, polysponin and miscleron in middle-aged and elderly patients with hypertension].
    Chaialo PP; Tokar' AV; Rudaia ES
    Vrach Delo; 1980 Nov; (11):52-3. PubMed ID: 7467262
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of coronary endothelial function by lovastatin.
    Misra A
    Natl Med J India; 1995; 8(6):271-2. PubMed ID: 8520448
    [No Abstract]   [Full Text] [Related]  

  • 17. [Better clinical outcome in coronary disease patients with lower level of low-density lipoprotein cholesterol].
    Zhao SP
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):865-7. PubMed ID: 16029518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Practice guidelines for physicians and related economic considerations].
    Simoons ML; Casparie AF
    Ned Tijdschr Geneeskd; 1999 Apr; 143(16):874-5. PubMed ID: 10347660
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease].
    Rdzanek H; Kochmański M; Zochowski RJ
    Wiad Lek; 1993 Apr; 46(7-8):245-9. PubMed ID: 8249409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin decreases mortality.
    Shaughnessy AF; Slawson DC
    J Fam Pract; 1995 May; 40(5):498-9. PubMed ID: 7730777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.